Columbia researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells.
Physician-scientist Juanma Schvartzman is a firm believer that his curiosity-driven research on cell metabolism and its influence on cell identity will offer clues for better cancer treatments.
Combining a diabetes drug with a cancer drug not only kills aggressive bladder cancer cells in mice, but also turns remaining malignant cells into a more benign state.
5 new leukemia clinician-scientists have joined the Herbert Irving Comprehensive Cancer Center at NYPH/CUMC: Drs. Mark Frattini, Mark Heaney, Joseph Jurcic, Nicole Lamanna, & Todd Rosenblat.
The Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center has welcomed five new clinician-scientists specializing in leukemia.
"Cancer biology is in the midst of a major transition that has led from a primary focus on oncogenes to a focus on systems," say the Columbia editorial authors, Dr. Victor Grann and Maxine Ashby-Thompson.